Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SBC Medical Group Holdings (SBC) Capital Expenditures (2023 - 2025)

Historic Capital Expenditures for Medical Group Holdings (SBC) over the last 3 years, with Q3 2025 value amounting to $43053.0.

  • Medical Group Holdings' Capital Expenditures fell 8947.24% to $43053.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 8547.39%. This contributed to the annual value of $2.6 million for FY2024, which is 6998.08% down from last year.
  • Per Medical Group Holdings' latest filing, its Capital Expenditures stood at $43053.0 for Q3 2025, which was down 8947.24% from $306706.0 recorded in Q2 2025.
  • In the past 5 years, Medical Group Holdings' Capital Expenditures registered a high of $6.2 million during Q4 2023, and its lowest value of $43053.0 during Q3 2025.
  • In the last 3 years, Medical Group Holdings' Capital Expenditures had a median value of $499655.0 in 2024 and averaged $1.2 million.
  • As far as peak fluctuations go, Medical Group Holdings' Capital Expenditures plummeted by 9054.57% in 2024, and later tumbled by 6387.13% in 2025.
  • Quarter analysis of 3 years shows Medical Group Holdings' Capital Expenditures stood at $6.2 million in 2023, then tumbled by 90.55% to $590358.0 in 2024, then tumbled by 92.71% to $43053.0 in 2025.
  • Its Capital Expenditures was $43053.0 in Q3 2025, compared to $306706.0 in Q2 2025 and $253725.0 in Q1 2025.